Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Visual Cortex | 7 | 2026 | 130 | 1.210 |
Why?
|
| Genetic Vectors | 14 | 2004 | 901 | 0.860 |
Why?
|
| Liver | 17 | 1999 | 1804 | 0.850 |
Why?
|
| Genetic Therapy | 13 | 2004 | 718 | 0.510 |
Why?
|
| Promoter Regions, Genetic | 10 | 1998 | 1216 | 0.510 |
Why?
|
| Retroviridae | 10 | 2004 | 182 | 0.490 |
Why?
|
| alpha 1-Antitrypsin | 10 | 1997 | 81 | 0.470 |
Why?
|
| Neurons | 6 | 2026 | 2013 | 0.430 |
Why?
|
| Models, Neurological | 4 | 2026 | 209 | 0.360 |
Why?
|
| Transfection | 6 | 1996 | 948 | 0.310 |
Why?
|
| Photic Stimulation | 6 | 2026 | 229 | 0.310 |
Why?
|
| Hepatocyte Growth Factor | 2 | 1999 | 35 | 0.300 |
Why?
|
| Transduction, Genetic | 5 | 1999 | 279 | 0.290 |
Why?
|
| Visual Fields | 2 | 2026 | 139 | 0.270 |
Why?
|
| Moloney murine leukemia virus | 4 | 1996 | 17 | 0.260 |
Why?
|
| Connectome | 2 | 2025 | 123 | 0.250 |
Why?
|
| Visual Perception | 1 | 2026 | 127 | 0.220 |
Why?
|
| Color Vision | 1 | 2024 | 10 | 0.220 |
Why?
|
| beta-Galactosidase | 3 | 1996 | 134 | 0.210 |
Why?
|
| Gene Expression Regulation | 5 | 1999 | 2345 | 0.200 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 1996 | 331 | 0.190 |
Why?
|
| Color | 1 | 2022 | 30 | 0.190 |
Why?
|
| Mice | 16 | 2026 | 18273 | 0.190 |
Why?
|
| Rats | 12 | 1999 | 3420 | 0.190 |
Why?
|
| Reflex, Pupillary | 1 | 2022 | 16 | 0.190 |
Why?
|
| Animals | 26 | 2026 | 34000 | 0.190 |
Why?
|
| Pupil | 1 | 2022 | 45 | 0.180 |
Why?
|
| Vision, Ocular | 1 | 2022 | 117 | 0.180 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 110 | 0.150 |
Why?
|
| Protein C | 1 | 1998 | 17 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 1999 | 302 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 6 | 2026 | 4716 | 0.130 |
Why?
|
| Factor X Deficiency | 1 | 1997 | 1 | 0.130 |
Why?
|
| Factor X | 1 | 1997 | 4 | 0.130 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 342 | 0.120 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1996 | 65 | 0.120 |
Why?
|
| Genes, ras | 1 | 1996 | 98 | 0.120 |
Why?
|
| Cyclins | 1 | 1996 | 93 | 0.120 |
Why?
|
| Adenoviridae | 1 | 1999 | 581 | 0.120 |
Why?
|
| ras Proteins | 1 | 1996 | 146 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 1996 | 187 | 0.110 |
Why?
|
| Liver Regeneration | 4 | 1999 | 39 | 0.110 |
Why?
|
| Visual Pathways | 2 | 2026 | 84 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 691 | 0.110 |
Why?
|
| Dendrites | 2 | 2025 | 184 | 0.100 |
Why?
|
| Animals, Newborn | 2 | 2004 | 1018 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1994 | 486 | 0.090 |
Why?
|
| Gene Expression | 3 | 1994 | 1494 | 0.090 |
Why?
|
| Hepatectomy | 4 | 1996 | 125 | 0.090 |
Why?
|
| Base Sequence | 4 | 1996 | 2746 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 1994 | 673 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 3487 | 0.080 |
Why?
|
| Liposomes | 1 | 1991 | 200 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 5 | 1999 | 1142 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 1994 | 1090 | 0.070 |
Why?
|
| Cell Division | 2 | 1999 | 713 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 1996 | 2909 | 0.070 |
Why?
|
| Acute-Phase Proteins | 2 | 1999 | 45 | 0.070 |
Why?
|
| 3T3 Cells | 2 | 1997 | 120 | 0.060 |
Why?
|
| RNA Polymerase II | 3 | 1996 | 89 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 1997 | 2558 | 0.060 |
Why?
|
| Male | 10 | 2025 | 64765 | 0.060 |
Why?
|
| Color Perception | 1 | 2024 | 10 | 0.050 |
Why?
|
| Mucopolysaccharidosis VII | 1 | 2004 | 4 | 0.050 |
Why?
|
| Orientation | 1 | 2024 | 30 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2026 | 309 | 0.050 |
Why?
|
| Glucuronidase | 1 | 2004 | 32 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1996 | 274 | 0.050 |
Why?
|
| Primates | 1 | 2024 | 81 | 0.050 |
Why?
|
| Liver Transplantation | 3 | 1992 | 1134 | 0.050 |
Why?
|
| DNA | 2 | 1999 | 1413 | 0.050 |
Why?
|
| Darkness | 1 | 2022 | 25 | 0.050 |
Why?
|
| Binding Sites | 2 | 1996 | 1143 | 0.050 |
Why?
|
| Spleen | 2 | 1995 | 255 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 1994 | 231 | 0.050 |
Why?
|
| Axons | 1 | 2025 | 388 | 0.050 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2022 | 74 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2022 | 89 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2022 | 191 | 0.040 |
Why?
|
| Synapses | 1 | 2025 | 448 | 0.040 |
Why?
|
| Dogs | 4 | 2004 | 616 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 1999 | 1949 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 84 | 0.040 |
Why?
|
| Cell Movement | 2 | 1995 | 868 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 105 | 0.040 |
Why?
|
| Drug Synergism | 1 | 1999 | 236 | 0.040 |
Why?
|
| Bromodeoxyuridine | 1 | 1999 | 56 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 188 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 1999 | 184 | 0.040 |
Why?
|
| Rats, Inbred Lew | 1 | 1998 | 57 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 1995 | 2344 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 1999 | 258 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 1999 | 230 | 0.030 |
Why?
|
| Serum Albumin | 2 | 1994 | 102 | 0.030 |
Why?
|
| NF-kappa B | 1 | 1999 | 450 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 1996 | 17 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 1996 | 20 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 98 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1996 | 80 | 0.030 |
Why?
|
| Toxins, Biological | 1 | 1996 | 39 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1997 | 432 | 0.030 |
Why?
|
| Portal Vein | 1 | 1996 | 88 | 0.030 |
Why?
|
| Carcinogens | 1 | 1996 | 128 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 1996 | 156 | 0.030 |
Why?
|
| Trans-Activators | 1 | 1999 | 684 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1997 | 397 | 0.030 |
Why?
|
| Phosphorylation | 1 | 1999 | 1569 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1996 | 233 | 0.030 |
Why?
|
| Galactosides | 1 | 1995 | 9 | 0.030 |
Why?
|
| Albumins | 1 | 1996 | 89 | 0.030 |
Why?
|
| Humans | 12 | 1999 | 130959 | 0.030 |
Why?
|
| Fluoresceins | 1 | 1995 | 30 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 85 | 0.030 |
Why?
|
| Fatty Acid-Binding Protein 7 | 1 | 1994 | 2 | 0.030 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 1994 | 9 | 0.030 |
Why?
|
| Methylation | 1 | 1995 | 197 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1994 | 36 | 0.030 |
Why?
|
| Cell Separation | 1 | 1995 | 220 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 1994 | 37 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1996 | 452 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 969 | 0.030 |
Why?
|
| Proviruses | 1 | 1994 | 19 | 0.030 |
Why?
|
| Indoles | 1 | 1995 | 201 | 0.030 |
Why?
|
| RNA, Viral | 1 | 1996 | 504 | 0.030 |
Why?
|
| Gene Dosage | 1 | 1995 | 439 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 1598 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 1994 | 340 | 0.020 |
Why?
|
| Biopsy | 1 | 1996 | 1241 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1995 | 772 | 0.020 |
Why?
|
| Time Factors | 1 | 2022 | 6231 | 0.020 |
Why?
|
| Female | 3 | 2025 | 70720 | 0.020 |
Why?
|
| Fatty Acids | 1 | 1994 | 377 | 0.020 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 1992 | 43 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1996 | 856 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2004 | 2100 | 0.020 |
Why?
|
| Transplantation, Heterotopic | 1 | 1991 | 15 | 0.020 |
Why?
|
| Tissue Transplantation | 1 | 1991 | 10 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1991 | 83 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1991 | 155 | 0.020 |
Why?
|
| Splenectomy | 1 | 1991 | 62 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 310 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1994 | 1458 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1991 | 126 | 0.020 |
Why?
|
| Apoptosis | 1 | 1996 | 1852 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1994 | 1018 | 0.020 |
Why?
|
| Transcription Factors | 2 | 1996 | 2442 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1996 | 2027 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1992 | 1314 | 0.020 |
Why?
|
| Signal Transduction | 1 | 1999 | 4672 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1996 | 1005 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1991 | 1382 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1991 | 984 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 1396 | 0.010 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2004 | 10 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2004 | 42 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 239 | 0.010 |
Why?
|
| Dog Diseases | 1 | 2004 | 58 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2004 | 234 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2004 | 174 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2004 | 251 | 0.010 |
Why?
|
| Lysosomes | 1 | 2004 | 269 | 0.010 |
Why?
|
| Aortic Valve | 1 | 2004 | 464 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 524 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2004 | 972 | 0.010 |
Why?
|
| Myocardium | 1 | 2004 | 865 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 675 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 1994 | 44 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 4683 | 0.010 |
Why?
|
| Retroviridae Proteins | 1 | 1992 | 10 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1992 | 261 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1992 | 423 | 0.010 |
Why?
|
| Forecasting | 1 | 1992 | 358 | 0.010 |
Why?
|
| Cell Survival | 1 | 1992 | 843 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 1215 | 0.000 |
Why?
|
| Models, Biological | 1 | 1992 | 1391 | 0.000 |
Why?
|
| Phenotype | 1 | 1992 | 4484 | 0.000 |
Why?
|